Researchers are exploring the potential of using donor CAR T cells to treat autoimmune diseases, a significant shift from traditional methods that rely on a patient's own cells. A recent study from China demonstrated promising results in three patients, suggesting that this approach could not only enhance treatment accessibility but also revolutionize how autoimmune conditions are managed. The ability to scale this therapy could lead to groundbreaking advancements in the field.
